Literature DB >> 26208797

Mechanisms of enhanced osteoclastogenesis in girls and young women with Turner's Syndrome.

Maria Felicia Faienza1, Giacomina Brunetti2, Annamaria Ventura3, Laura Piacente3, Maria Francesca Messina4, Filippo De Luca4, Maria Ciccarelli3, Angela Oranger5, Giorgio Mori6, Maria Pia Natale3, Margherita Gigante7, Elena Ranieri8, Loreto Gesualdo7, Silvia Colucci5, Luciano Cavallo3, Maria Grano5.   

Abstract

Subjects with hypergonadotropic hypogonadism due to Turner's syndrome show low cortical mineral density, osteoporosis and risk of fractures. It is not clear if this bone fragility derives from chromosomal abnormalities or is the result of inadequate bone formation due to estrogen deficiency. The aim of this study was to investigate the cellular mechanisms underlying bone fragility in subjects with Turner's syndrome before induction of puberty and after hormonal replacement therapy (HRT). For this purpose, we have evaluated the osteoclastogenic potential of non-fractioned and T-cell depleted cultures of peripheral blood mononuclear cells (PBMCs) belonging to girls with Turner's syndrome who had not been treated with HRT yet, girls and young women who were on HRT and age-matched controls. Untreated subjects showed high FSH serum levels, whereas the other subjects displayed normal FSH serum levels. T-cell immunophenotype was analyzed through flow cytometry. Biochemical and DXA analyses were performed. Spontaneous osteoclastogenesis in non-fractioned and T-cell depleted cultures of PBMC belonging to girls with high FSH levels was more evident than in cultures of subjects with normal FSH levels. In the former, osteoclastogenesis was sustained by monocytes expressing high levels of c-fms, TNF-α and RANK, and T-cells producing high RANKL and TNF-α; in the latter it was supported by T-cells expressing high RANKL levels. CD4(+)CD25(high) T-cells were reduced in all subjects, whereas CD3(+)/CD16(+)/CD56(+) NKT-cells were increased in those with high FSH levels. High RANKL and CTX levels were detected in the sera. Bone impairment was already detectable by DXA in subjects aged under 10, although it became more evident with aging. In conclusion, our results demonstrated that bone fragility in subjects with Turner's syndrome is associated to enhanced osteoclastogenesis. This process seems to be due to high FSH serum levels before HRT, whereas it is caused by high RANKL during HRT.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FSH; Osteoclastogenesis; RANKL; T cells; Turner's syndrome

Mesh:

Substances:

Year:  2015        PMID: 26208797     DOI: 10.1016/j.bone.2015.07.021

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  10 in total

1.  Follicle-stimulating hormone enhances alveolar bone resorption via upregulation of cyclooxygenase-2.

Authors:  Chunxia Zhu; Yaoting Ji; Shengbo Liu; Zhuan Bian
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

2.  Body composition and bone mineral status in patients with Turner syndrome.

Authors:  Kun Shi; Li Liu; Yao-Juan He; Duan Li; Lian-Xiong Yuan; Gendie E Lash; Li Li
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

3.  CD31hiEmcnhi Vessels Support New Trabecular Bone Formation at the Frontier Growth Area in the Bone Defect Repair Process.

Authors:  Jimeng Wang; Yi Gao; Pengzhen Cheng; Donglin Li; Huijie Jiang; Chuanlei Ji; Shuaishuai Zhang; Chao Shen; Junqin Li; Yue Song; Tianqing Cao; Chunmei Wang; Liu Yang; Guoxian Pei
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

4.  Rare copy number variants in the genome of Chinese female children and adolescents with Turner syndrome.

Authors:  Li Li; Qingfeng Li; Qiong Wang; Li Liu; Ru Li; Huishu Liu; Yaojuan He; Gendie E Lash
Journal:  Biosci Rep       Date:  2019-01-11       Impact factor: 3.840

Review 5.  What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss?

Authors:  Teun J de Vries; Ismail El Bakkali; Thomas Kamradt; Georg Schett; Ineke D C Jansen; Patrizia D'Amelio
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

Review 6.  Mechanisms of Bone Impairment in Sickle Bone Disease.

Authors:  Paola Giordano; Flavia Urbano; Giuseppe Lassandro; Maria Felicia Faienza
Journal:  Int J Environ Res Public Health       Date:  2021-02-13       Impact factor: 3.390

7.  Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome.

Authors:  M Chiarito; L Piacente; N Chaoul; P Pontrelli; G D'Amato; A Grandone; G Russo; M E Street; M G Wasniewska; G Brunetti; M F Faienza
Journal:  J Endocrinol Invest       Date:  2022-03-02       Impact factor: 5.467

Review 8.  Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies.

Authors:  Maria Felicia Faienza; Annamaria Ventura; Silvia Colucci; Luciano Cavallo; Maria Grano; Giacomina Brunetti
Journal:  Front Endocrinol (Lausanne)       Date:  2016-04-26       Impact factor: 5.555

9.  Editorial: Updates on Osteoimmunology: What's New on the Crosstalk Between Bone and Immune Cells.

Authors:  Giacomina Brunetti; Patrizia D'Amelio; Giorgio Mori; Maria Felicia Faienza
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-20       Impact factor: 5.555

10.  Editorial: Advances in Endocrinology: Stem Cells and Growth Factors.

Authors:  Andrea Ballini; Salvatore Scacco; Rajiv Saini; Stefania Cantore; Giorgio Mori
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-14       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.